Creative Biolabs-Lipid Based Drug Delivery

Custom Cholesterol-PEG Conjugate Service

Background Our Services Workflow Applications Why Choose Us Related Services

At Creative Biolabs, we understand that the translation of advanced therapeutics—from small-molecule chemotherapeutics to fragile nucleic acids—hinges entirely on the precision of your delivery vehicle. Our Custom Cholesterol-PEG Conjugates Synthesis Service provides researchers, pharmaceutical developers, and biotechs worldwide with highly specialized, custom-synthesized amphiphilic molecules. By combining the rigid, membrane-stabilizing properties of cholesterol with the hydrophilic, stealth-conferring capabilities of poly(ethylene glycol) (PEG), we help you engineer lipid-based drug delivery systems (LNPs, liposomes, and niosomes) with optimized pharmacokinetics, superior cellular uptake, and unmatched in vivo stability.

Why Choose Cholesterol-PEG Conjugates?

In the design of lipid-based drug delivery systems (DDS), conventional pegylated lipids like DSPE-PEG can trigger the Accelerated Blood Clearance (ABC) phenomenon upon repeated intravenous administration. This results in rapid clearance by the mononuclear phagocyte system (MPS) and a diminished therapeutic index.

PEG-Cholesterol (PEG-Chol) conjugates offer a highly biocompatible, low-immunogenic alternative that transforms nanomedicine performance through several key mechanisms:

PEGylated cholesterol. (Creative Biolabs Original) Fig. 1 Chol-PEGn Derivatives.

  • Mitigation of the ABC Phenomenon: Biodegradable PEG-Chol conjugates exhibit modified biological recognition profiles, significantly reducing unwanted immunological clearance compared to standard phospholipid conjugates.
  • Fine-Tuned Fixed Aqueous Layer Thickness: By altering the molecular weight of the PEG chain (from PEG400 up to PEG20,000), we help you control the steric barrier surrounding your nanoparticles, balancing long circulation half-lives with optimal cell membrane interaction.
  • Clathrin-Independent Cellular Uptake: Formulations utilizing PEG-Chol conjugates are preferentially internalized via clathrin-independent pathways (including caveolae-mediated endocytosis), bypassing rapid lysosomal degradation and routing your cargo directly into the endosome and Golgi apparatus.
  • Triggered DePEGylation & Endosomal Escape: We design and synthesize acid-labile (pH-sensitive) or reduction-sensitive (disulfide S-S) linkers between the cholesterol and PEG blocks. Upon encountering the acidic tumor microenvironment (pH ~ 6.5), endosomes, or glutathione-rich intracellular spaces, the PEG shell is shed, triggering cargo release and facilitating cytosolic delivery.
Get a Quote

Accelerate Your Pre-Clinical Formulation Research

Unlock the full potential of your lipid nanoparticles. Speak with a PhD-level formulation chemist today to discuss your target specifications and receive a tailored project proposal.

Request a Quote

Our Custom Synthesis Capabilities

Creative Biolabs offers an expansive portfolio of chemical modifications to tailor your PEG-Cholesterol conjugates to your exact biological objectives:

  • Custom Terminal Functionalization We introduce a wide range of functional groups at the distal end of the PEG chain, including amine, carboxyl, thiol, NHS ester, maleimide, and click-chemistry compatible groups (azide, alkyne) to facilitate seamless bioconjugation of targeting ligands.
  • Smart, Stimuli-Responsive Linker Chemistry Our synthetic team can insert custom environmental-responsive linkages between the cholesterol anchor and the PEG block, including reduction-sensitive disulfide (S-S) bonds or pH-sensitive ester, hydrazone, and carbonate bonds for controlled intracellular release.
  • Monodisperse and Polydisperse PEG Scaling We offer high-purity polydisperse PEG options spanning from 1kDa to 20 kDa, alongside high-precision monodisperse PEG chains (n = 4, 8, 12, 24, 36, 48) that ensure absolute molecular weight uniformity for strict regulatory compliance.
  • Comprehensive Analytical Characterization To guarantee uncompromising quality, every custom conjugate batch is thoroughly validated and supplied with a detailed Certificate of Analysis (CoA) containing robust validation data from 1H-NMR, HPLC-CAD/ELSD, and MALDI-TOF mass spectrometry.

Workflow

Contact & requirements One-to-one technical support Submit custom service form Project start Product delivery Optional Pharmacodynamic Study Analysis and Characterization

Applications in Advanced Drug Delivery

  • mRNA & Gene Therapy LNPs: Optimize lipid nanoparticle stealth coatings, control particle size, and regulate extrahepatic tissue-specific biodistribution.
  • Stealth Liposomes & Niosomes: Prolong circulation half-life and minimize systemic clearance by creating an ultra-stable hydrophilic steric barrier against opsonization.
  • Self-Assembling Polymeric Micelles: Form stable micelles with ultra-low critical micelle concentrations for solubilizing and delivering highly hydrophobic active pharmaceutical ingredients.

Why Choose Creative Biolabs?

  • Profound Scientific Expertise: With over 20 years of experience in lipid-based drug delivery systems, our PhD-level chemists provide consultative guidance on molecular design to optimize your in vivo results.
  • Strict Quality Control: Every custom conjugate undergoes multi-step purification and rigorous characterization to ensure chemical purity exceeds ≥ 95% with minimal batch-to-batch variation.
  • Seamless Scalability: We easily adapt to your project's life cycle, providing flexible production scales ranging from milligram development pilots to bulk, preclinical-grade kilograms.
  • Full Intellectual Property Protection: We adhere to strict confidentiality and secure IP protocols, ensuring your proprietary molecular structures and research pipelines remain entirely your own.

Accelerate your timeline to the clinic. Contact our customer-centric sales and scientific team today to get a competitive quote and detailed technical consultation on your custom Cholesterol-PEG project.

Related Services

For Research Use Only. Not For Clinical Use

Services

Lipid-based Delivery System Development Formulation Analysis & Characterization Pharmacodynamic Study

Online Inquiry